IMR Press / CEOG / Volume 45 / Issue 2 / DOI: 10.12891/ceog3820.2018

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Depression, anxiety, and stress after preterm delivery: role of previous progesterone therapy
Show Less
1 Gynaecology and Obstetrics Clinic “Narodni front”, Belgrade, Serbia
Clin. Exp. Obstet. Gynecol. 2018, 45(2), 214–217;
Published: 10 April 2018

Purpose of the study: To determine the influence of progesterone therapy in imminent preterm delivery on early postpartum anxiety, stress, and depression symptoms and to compare the scores of two scales: the Depression, Anxiety and Stress Scale (DASS) and the Edinburgh Postpartum Depression Scale (EPDS) on third day postpartum. Materials and Methods: The sample consisted of 37 women on progesterone therapy between 28 and 37 weeks who delivered prematurely. Controls were 40 pregnant women without progesterone therapy who also delivered prematurely. On third postpartum day all participants completed DASS and EPDS. Student's t-test (Leven correction for small samples) compared the scores of these two scales. Results: The control group showed significantly higher levels of depression symptoms in DASS questionnaire on third day after preterm delivery. Conclusions: Progesterone lowers the intensity of depressive symptoms after preterm delivery. The DASS scoring system was effective in early detection of postpartum depressive symptoms.
Progesterone therapy
Preterm delivery
Postpartum depression
Back to top